BlackRock Group’s Acadia Pharmaceuticals ACAD Stock Holding History

BlackRock Group’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.59M	Sell	89,888 -51,037	-36%	-$1.35M	﹤0.01%	1583
2016 Q3	$4.48M	Buy	140,925 +14,698	+12%	+$498K	﹤0.01%	1160
2016 Q2	$4.1M	Buy	126,227 +41,846	+50%	+$1.4M	﹤0.01%	1174
2016 Q1	$2.36M	Buy	84,381 +24,237	+40%	+$528K	﹤0.01%	1435
2015 Q4	$2.14M	Buy	60,144 +4,468	+8%	+$157K	﹤0.01%	1445
2015 Q3	$1.84M	Buy	55,676 +9,461	+20%	+$394K	﹤0.01%	1540
2015 Q2	$1.94M	Buy	46,215 +4,500	+11%	+$174K	﹤0.01%	1576
2015 Q1	$1.36M	Buy	41,715 +11,630	+39%	+$400K	﹤0.01%	1687
2014 Q4	$955K	Buy	30,085 +5,281	+21%	+$150K	﹤0.01%	1907
2014 Q3	$615K	Sell	24,804 -360	-1%	-$8.42K	﹤0.01%	2070
2014 Q2	$569K	Sell	25,164 -18,341	-42%	-$383K	﹤0.01%	2149
2014 Q1	$1.06M	Buy	43,505 +21,472	+97%	+$543K	﹤0.01%	1966
2013 Q4	$550K	Sell	22,033 -249,428	-92%	-$5.88M	﹤0.01%	2199
2013 Q3	$7.46M	Sell	271,461 -294,300	-52%	-$6.15M	0.01%	990
2013 Q2	$10.3M	Buy	+565,761	New	+$7.79M	0.01%	855

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return